Medigene (MDG1) News Today €0.13 0.00 (0.00%) As of 05/15/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlinesBuy This Stock MDG1 Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Medigene bestellt neuen Vorstand - CEO Selwyn Ho gehtJuly 19, 2025 | finanznachrichten.dePTA-Adhoc: Medigene AG: Ausscheiden des Vorstandsvorsitzenden Dr. Selwyn Ho und Bestellung von Ralph Schäfer als VorstandJuly 18, 2025 | finanznachrichten.deMedigene verlässt Prime Standard wegen InsolvenzverfahrenJune 13, 2025 | finanznachrichten.dePTA-News: Medigene AG: Medigene AG hat Eröffnung des Insolvenzverfahrens beantragt - Einberufung zur aoHV nach §92 AktG entfälltApril 29, 2025 | finanznachrichten.dePTA-Adhoc: Medigene AG: Medigene AG stellt Antrag auf Eröffnung eines InsolvenzverfahrensApril 7, 2025 | finanznachrichten.deMedigene Files Patent for Unique NK-Specific TCR Construct with European Patent OfficeMarch 13, 2025 | markets.businessinsider.comMedigene and EpimAb to develop T cell engagers for solid tumoursFebruary 28, 2025 | finance.yahoo.comPTA-News: Medigene AG: Medigene und EpimAb Biotherapeutics schließen Co-Entwicklungspartnerschaft für TCR-gesteuerte T-Zell-Engager abFebruary 27, 2025 | finanznachrichten.deMedigene and EpimAb Biotherapeutics Enter into a Co-Development Partnership for TCR-Guided T Cell EngagersFebruary 27, 2025 | markets.businessinsider.comPTA-News: Medigene AG: Medigene AG erweitert Patentportfolio um Patenterteilung für seine JOVI Technologie in den USAFebruary 20, 2025 | finanznachrichten.deMedigene AG: Kapitalerhöhung bringt 0,25 Millionen Euro von YorkvilleFebruary 5, 2025 | finanznachrichten.dePTA-News: Medigene AG: Medigene AG gibt Abschluss der ersten SEPA Tranche bekanntFebruary 3, 2025 | finanznachrichten.deMedigene: Wer RuMaS Trading-Tipps nicht nutzt, ist selbst schuld!January 27, 2025 | finanznachrichten.dePTA-News: Medigene AG: Medigene AG erweitert Patentportfolio um Patenterteilung für den gegen MAGE-A4 gerichteten T-Zell-Rezeptor in JapanJanuary 14, 2025 | finanznachrichten.dePTA-News: Medigene AG: Medigene AG reicht Antrag auf klinische Prüfung in Europa für MDG1015 für mehrere solide Tumorindikationen einDecember 18, 2024 | finanznachrichten.dePTA-News: Medigene AG: Umstrukturierung / PersonalabbauNovember 26, 2024 | finanznachrichten.deMedigene AG Announces Refocus of Corporate Strategy and Organizational RealignmentNovember 26, 2024 | finance.yahoo.comPTA-News: Medigene AG: Medigene präsentiert Daten zu innovativer IFN-Gamma-Biosensor-Technologie bei SITC 2024November 13, 2024 | finanznachrichten.deMedigene Presents Data on an Innovative IFN-γ Biosensor Technology at SITC 2024November 12, 2024 | markets.businessinsider.comPTA-News: Medigene AG: Medigene präsentiert neuste Daten zur UniTope- und TraCR-Technologie auf der PEGS- und SITC-Konferenz 2024November 11, 2024 | finanznachrichten.deMedigene Presents Latest Data on UniTope & TraCR Technology at PEGS and SITC 2024November 11, 2024 | markets.businessinsider.comMedigene Presents Unique Approach for Use of Optimal T Cell Receptors in TCR-Guided Modalities at Cell 2024November 8, 2024 | finance.yahoo.comCan Medigene (ETR:MDG1) Afford To Invest In Growth?November 6, 2024 | finance.yahoo.comPTA-News: Medigene AG: Medigene AG veröffentlicht Geschäftszahlen und Business Update für Q3 2024October 24, 2024 | finanznachrichten.deMedigene AG reports Financial Results and Business Update for Q3 2024October 24, 2024 | tmcnet.comMedigene presents UniTope and TraCR a universal detection system for 3S recombinant TCRs at ASGCT 2024October 17, 2024 | markets.businessinsider.comPTA-News: Medigene AG: Medigene präsentiert auf folgenden wissenschaftlichen KonferenzenOctober 16, 2024 | finanznachrichten.dePTA-News: Medigene AG: Medigene präsentiert auf der ASGCT 2024 und hält F&E-Veranstaltung abOctober 2, 2024 | finanznachrichten.deMedigene will Present at ASGCT 2024 and Host R&D EventOctober 2, 2024 | markets.businessinsider.comFormycon AG (FYB.F) Stock Price, News, Quote & History - Yahoo FinanceSeptember 24, 2024 | finance.yahoo.com4SC AG (VSC.F) Stock Price, News, Quote & History - Yahoo FinanceSeptember 24, 2024 | finance.yahoo.comMedigene to Host Virtual R&D Event on Medigene’s Optimal 3S TCRs for TCR-Guided Precision ImmunotherapiesSeptember 16, 2024 | markets.businessinsider.comMedigene AG (MDG1.SG)August 29, 2024 | nz.finance.yahoo.comMedigene AG (MDG1.MU)August 29, 2024 | nz.finance.yahoo.comMedigene AG (MDG1.VI)August 29, 2024 | uk.finance.yahoo.comMedigene AG (MDG1.HM)August 29, 2024 | nz.finance.yahoo.comMedigene to Present at Upcoming Investor ConferencesAugust 28, 2024 | markets.businessinsider.comMedigene Second Quarter 2024 Earnings: Beats ExpectationsAugust 17, 2024 | finance.yahoo.comMunich Re sees market volatility to continue for weeks or monthsAugust 9, 2024 | uk.finance.yahoo.comWuXi Biologics and Medigene link on T cell engagers for cancerAugust 9, 2024 | finance.yahoo.comMedigene AG (MDG1.BE)July 30, 2024 | sg.finance.yahoo.comMedigene to Present at ESMO Congress 2024July 23, 2024 | markets.businessinsider.comMedigene AG: Medigene Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRASMay 15, 2024 | finanznachrichten.deMedigene Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRASMay 15, 2024 | finance.yahoo.comMedigene AG Extends Cash Runway into July 2025 After Successful Oversubscribed Capital RaiseMay 14, 2024 | finance.yahoo.comMedigene Presents Superior TCR-T Cell Functionality by Inclusion of a Costimulatory Switch ProteinMay 2, 2024 | markets.businessinsider.comMedigene AG reports Financial Results and Business Update for Q1 2024April 26, 2024 | finance.yahoo.comMedigene presents streamlined 6-day, high stemness TCR-T therapy production processApril 25, 2024 | finance.yahoo.comPTA-Adhoc: Medigene AG: Medigene AG führt Bezugsrechtskapitalerhöhung mit Backstop-Vereinbarung durchApril 22, 2024 | finanznachrichten.deMedigene to Present at Upcoming Scientific ConferencesApril 17, 2024 | finance.yahoo.com Get Medigene News Delivered to You Automatically Sign up to receive the latest news and ratings for MDG1 and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MDG1 Media Mentions By Week MDG1 Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MDG1 News Sentiment▼0.001.03▲Average Medical News Sentiment MDG1 News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MDG1 Articles This Week▼00▲MDG1 Articles Average Week Get the Latest News and Ratings for MDG1 and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Medigene and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Genfit News Today Biotest Aktiengesellschaft News Today Fielmann Group News Today Fresenius SE & Co. KGaA News Today Sanofi News Today Sartorius Stedim Biotech News Today Siemens Healthineers News Today Merck KGaA News Today Bayer Aktiengesellschaft News Today Fresenius Medical Care News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ETR:MDG1) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medigene AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Medigene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access